Merck Frosst
Home

Media Contact

Corporate communications

Vincent Lamoureux - 514-428-3456
Corporate spokesperson


Product-related communications

Sheila Murphy - 514-428-2748

Products
EZETROL®
GARDASIL®
MENJUGATE®
MMR®II
PNEUMOVAX®
RABAVERT®
ROTATEQ®
RECOMBIVAX®
VARIVAX®III
VAQTA®

Research and Development
Postherpetic neuralgia (PHN) / Shingles


Martine Drolet - 514-428-3037

Products
CANCIDAS®
COSOPT®
COZAAR®
EMENDTM
FOSAMAX®
FOSAVANCE®
INVANZ®
ISENTRESSTM
JANUVIATM
MAXALT®
SINGULAIR®

Research and Development
Obesity
Oncology


® Registered Trademark of Merck & Co., Inc. Used under license.
TM Trademark of Merck & Co., Inc. Used under license.

COZAAR® is a Registered Trademark of E.I. du Pont de Nemours and Company, Wilmington, Delaware, U.S.A. Used under license.

EZETROL® is a Registered trademark used under license by Merck Frosst-Schering Pharma, G.P.

Menjugate® is a Registered Trademark of Chiron Corporation.
RabAvert® is a Registered trademark of Chiron-Behring GmbH & Co KG.

This site is for residents of Canada. / This site was updated on November 24th, 2008.